Katia Tonkin - Concepedia

Author

Katia Tonkin

Also Known As

K S Tonkin, K Tonkin, K, Tonkin, K. S. Tonkin, K. Tonkin, K.S. TONKIN, K.S. Tonkin, Katia S Tonkin, Katia S. Tonkin, Katia Sonia Tonkin

110

Publications

Citations

H-Index

Concepts

All Affiliations

University of Alberta BC Cancer Agency Juravinski Cancer Centre Cancer Institute (WIA)Princess Margaret Cancer Centre

About

Katia Tonkin is an author at University of Alberta specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	21	32	2.7K
2	Health Sciences	8	8	541
3	Cell Biology	5	5	172
4	Nursing	2	2	35
5	Endocrinology	2	2	81

Katia Tonkin

Publications

8.6K

Citations

H-Index

Page 1

	Year	Citations
Denosumab Compared With Zoledronic Acid for the Treatment of Bone Metastases in Patients With Advanced Breast Cancer: A Randomized, Double-Blind Study Alison Stopeck, Allan Lipton, Jean-Jacques Body, Journal of Clinical Oncology	2010	1.6K
Olaparib in patients with recurrent high-grade serous or poorly differentiated ovarian carcinoma or triple-negative breast cancer: a phase 2, multicentre, open-label, non-randomised study Karen A. Gelmon, Marc Tischkowitz, Helen Mackay, The Lancet Oncology Breast OncologyMedicineGynecologyBreast CancerTriple-negative Breast Cancer	2011	1.1K
Sarcopenia as a Determinant of Chemotherapy Toxicity and Time to Tumor Progression in Metastatic Breast Cancer Patients Receiving Capecitabine Treatment Carla M. Prado, Vickie E. Baracos, Linda J. McCargar, Clinical Cancer Research	2009	1.1K
Randomized Active-Controlled Phase II Study of Denosumab Efficacy and Safety in Patients With Breast Cancer-Related Bone Metastases Allan Lipton, Guenther G. Steger, Jazmín Meneses Figueroa, Journal of Clinical Oncology	2007	382
Phase II Study of Temsirolimus in Women With Recurrent or Metastatic Endometrial Cancer: A Trial of the NCIC Clinical Trials Group Amit M. Oza, Laurie Elit, Ming‐Sound Tsao, Journal of Clinical Oncology	2011	333
Elevated plasma osteopontin in metastatic breast cancer associated with increased tumor burden and decreased survival. Hemant Singhal, D Bautista, Katia Tonkin, PubMed Opn Blood LevelsTumor BiologyIncreased Tumor BurdenMetastatic Breast CancerOncology	1997	285
Adjuvant denosumab in early breast cancer (D-CARE): an international, multicentre, randomised, controlled, phase 3 trial Robert E. Coleman, Dianne M. Finkelstein, Carlos H. Barrios, The Lancet Oncology	2019	244
Osteopontin expression in a group of lymph node negative breast cancer patients Alan B. Tuck, Frances P. O’Malley, Hemant Singhal, International Journal of Cancer	1998	218
Associations among exercise, body weight, and quality of life in a population-based sample of endometrial cancer survivors Kerry S. Courneya, Kristina H. Karvinen, Kristin L. Campbell, Gynecologic Oncology ObesityQuality Of LifePopulation-based SamplePhysical ActivityExercise	2005	204
Safety of long-term denosumab therapy: results from the open label extension phase of two phase 3 studies in patients with metastatic breast and prostate cancer Alison Stopeck, Karim Fizazi, Jean-Jacques Body, Supportive Care in Cancer	2015	187

Page 1